An exciting Precision Medicine in Oncology event will take place at the Francis Crick Institute in London on Tuesday, March 18th, 2025, from 2:00 to 7:00 PM.

The event, which brings together several partner organizations, will feature talks, discussions, networking opportunities, and career drop-ins. A highlight will be a presentation by Professor Allan Bradley, the founder and CEO of T-Therapeutics Ltd and Emeritus Director of the Wellcome Sanger Institute, who will share insights about translating discoveries into impact, along with talks from other scientists who have commercialised their research.